Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
Zirui Qiu, Yawen Zhao, Tao Tian, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3184-3184
Open Access | Times Cited: 12

Showing 12 citing articles:

Role of genetics in inflammatory cardiomyopathy
Paul J. Scheel, Iside Cartella, Brittney Murray, et al.
International Journal of Cardiology (2024) Vol. 400, pp. 131777-131777
Closed Access | Times Cited: 14
SFRP4 Knockdown Attenuates Dsg2-Deficient Arrhythmogenic Cardiomyopathy by Down-Regulating TGF-β and Smad3
Wei Li, Mei‐Xiang Wang, Zhongbao Ruan, et al.
Biochemical Genetics (2025)
Closed Access
Gene editing innovations and their applications in cardiomyopathy research
Eirini Kyriakopoulou, Thomas Monnikhof, Eva van Rooij
Disease Models & Mechanisms (2023) Vol. 16, Iss. 5
Open Access | Times Cited: 10
Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models
Christianne J. Chua, Justin Morrissette‐McAlmon, Leslie Tung, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1864-1864
Open Access | Times Cited: 9
Basic and translational mechanisms in inflammatory arrhythmogenic cardiomyopathy
Morgan Engel, Emily Shiel, Stephen P. Chelko
International Journal of Cardiology (2023) Vol. 397, pp. 131602-131602
Closed Access | Times Cited: 7
Recent Insights into the Role of PPARs in Disease
Nicole Wagner, Kay‐Dietrich Wagner
Cells (2023) Vol. 12, Iss. 12, pp. 1572-1572
Open Access | Times Cited: 6
Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect
Abdul Majid, Fasilat Oluwakemi Hassan, Md Monirul Hoque, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 313-313
Open Access | Times Cited: 4
Fenofibrate Induces a Resolving Profile in Heart Macrophage Subsets and Attenuates Acute Chagas Myocarditis
Javier Luque, Ágata Carolina Cevey, Azul Victoria Pieralisi, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1793-1807
Closed Access | Times Cited: 1
Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
Karen R. Gaar-Humphreys, Alyssa van den Brink, Mark Wekking, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Management Strategies in Arrhythmogenic Cardiomyopathy across the Spectrum of Ventricular Involvement
Yash Maniar, Nisha A. Gilotra, Paul J. Scheel
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3259-3259
Open Access | Times Cited: 2
Animal Models and Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy Associated with Pathogenic Variants in Intercalated Disc Genes
Sara Vencato, Chiara Romanato, Alessandra Rampazzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6208-6208
Open Access
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models
Giovanni Risato, Raquel Brañas Casas, Marco Cason, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1264-1264
Open Access
Page 1

Scroll to top